Frontiers in Neuroscience (Mar 2020)

Platelets in Amyloidogenic Mice Are Activated and Invade the Brain

  • Kathrin M. Kniewallner,
  • Kathrin M. Kniewallner,
  • Diana M. Bessa de Sousa,
  • Diana M. Bessa de Sousa,
  • Michael S. Unger,
  • Michael S. Unger,
  • Heike Mrowetz,
  • Heike Mrowetz,
  • Ludwig Aigner,
  • Ludwig Aigner,
  • Ludwig Aigner

DOI
https://doi.org/10.3389/fnins.2020.00129
Journal volume & issue
Vol. 14

Abstract

Read online

Alzheimer’s disease (AD) is a neurodegenerative disease with a complex and not fully understood pathogenesis. Besides brain-intrinsic hallmarks such as abnormal deposition of harmful proteins, i.e., amyloid beta in plaques and hyperphosphorylated Tau in neurofibrillary tangles, blood-derived elements, in particular, platelets have been discussed to be involved in AD pathogenesis. The underlying mechanisms, however, are rather unexplored. Here, we investigate a potential role of platelets in an AD transgenic animal model with severe amyloid plaque formation, the APP-PS1 transgenic mice, and analyzed the presence, spatial location and activation status of platelets within the brain. In APP-PS1 mice, a higher number of platelets were located within the brain parenchyma, i.e., outside the cerebral blood vessels compared to WT controls. Such platelets were activated according to the expression of the platelet activation marker CD62P and to morphological hallmarks such as membrane protrusions. In the brain, platelets were in close contact exclusively with astrocytes suggesting an interaction between these two cell types. In the bloodstream, although the percentage of activated platelets did not differ between transgenic and age-matched control animals, APP-PS1 blood-derived platelets showed remarkable ultrastructural peculiarities in platelet-specific organelles such as the open canalicular system (OCS). This work urges for further investigations on platelets and their yet unknown functional roles in the brain, which might go beyond AD pathogenesis and be relevant for various age-related neurodegenerative diseases.

Keywords